Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk
Although the biochemical and pathological hallmarks of Alzheimer’s disease (AD), such as axonal transport defects, synaptic loss, and selective neuronal death, are well characterized, the underlying mechanisms that cause AD are largely unknown, thereby making it difficult to design effective therape...
Main Authors: | Sreedevi Raman, Nicholas Brookhouser, David A. Brafman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996120300632 |
Similar Items
-
Genetic Cardiomyopathies: The Lesson Learned from hiPSCs
by: Ilaria My, et al.
Published: (2021-03-01) -
Exploiting hiPSCs in Leber's Hereditary Optic Neuropathy (LHON): Present Achievements and Future Perspectives
by: Camille Peron, et al.
Published: (2021-06-01) -
Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish
by: Alba Pensado-López, et al.
Published: (2020-11-01) -
The Role of MicroRNAs in Early Chondrogenesis of Human Induced Pluripotent Stem Cells (hiPSCs)
by: Ewelina Stelcer, et al.
Published: (2019-09-01) -
May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
by: Nicholas Brookhouser, et al.
Published: (2017-02-01)